- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07430800
Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
SCH: Personalized AI-Driven Models for Supporting User Engagement and Adherence in Health Interventions: Validation in Cognitive Behavioral Therapy for Anxiety
Study Overview
Status
Conditions
Detailed Description
The investigators will conduct a Phase 1 parallel intervention study with random assignment. The investigators will randomly assign consented college students reporting anxiety symptoms to one of two 6-week Cognitive Behavioral Therapy (CBT) exercise conditions that were validated in our preliminary studies. The participant will be randomly assigned to a condition (personalized versus not personalized socially assistive robot (SAR) CBT) and will be informed of their condition by the investigators when the participant is ready to start their home practice with the SAR CBT companion. During the initial baseline in-home visit, participants will be provided with a SAR and instructions for how to complete their SAR CBT exercises daily for 6 weeks. During the 6-week home-based study period that follows the baseline visit, the participant will be reminded daily to complete a CBT exercise with their SAR. The investigators will be the point of contact via phone or email for all participants who need assistance (e.g., with SAR/software issues).
The investigators will evaluate personalized re-engagement strategies derived from implicit feedback from individuals with clinically elevated anxiety. This will be done through an in-home between-subjects user study involving 60 student participants who will be randomly assigned to either a control condition without re-engagement feedback or a personalized feedback condition with personalized re-engagement feedback. Quantitative behavioral and subjective metrics will be compared between the conditions to assess the impact of personalized feedback on feelings of relatedness with the robot, intrinsic motivation, engagement, and adherence, guided by self-determination theory. The study aims to determine whether personalized re-engagement feedback enhances the intrinsic motivation, engagement, and adherence when using the SAR companion to deliver CBT concepts to individuals with clinically elevated anxiety.
The second aim is to evaluate the personalization of robot attributes based on explicit user feedback in individuals with clinically elevated anxiety. This will be done through an in-home between-subjects user study where 60 participants are randomly assigned to either a control condition without the capability to personalize the robot's attributes or a personalization condition where the participant can modify the robot's attributes at the start of the study and between CBT sessions. This study aims to determine whether granting users the ability to choose the robot's attributes will lead to higher levels of intrinsic motivation, engagement, and adherence during interaction with the SAR companion.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90089
- Recruiting
- University of Southern California
-
Contact:
- Lydia Ignatova
- Phone Number: 714-855-7076
- Email: lignatov@usc.edu
-
Contact:
- Emily Weiss
- Phone Number: 402-237-2492
- Email: emilymwe@usc.edu
-
Principal Investigator:
- Maja Matarić, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Are 18 years of age or older
- Are university students
- Are able to communicate in English
- Have corrected-to-normal vision and hearing
- Consent to have audio/video/interaction data recorded as part of the study
- Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 5 or greater, indicating mild to elevated levels of self-reported symptoms of anxiety
- Have a lower than minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("NO" responses to items 3, 4, 5, and 6 on C-SSRS)
- Having access to home WiFi
Exclusion Criteria:
- Are less than 18 years of age
- Are not university students
- Are not able to communicate in English
- Do not have corrected-to-normal vision and hearing
- Do not consent to have audio/video/interaction data recorded as part of the study
- Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 4 or lower.
- Higher than a minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("YES" responses to items 3, 4, 5, or 6 on C-SSRS)
- Don't have access to home WiFi
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Explicit CBT SAR Personalization for 6 weeks
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBT daily exercises with an explicitly personalized CBT SAR in the participants' homes.
Each participant will receive personalized re-engagement feedback delivered by the SAR will be based on explicit user feedback regarding the participant's subjective preferences related to the robot attributes and engagement features.
|
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBT daily exercises with an explicitly personalized CBT SAR in the participants' homes.
Participants will receive personalized re-engagement feedback delivered by the SAR will be based on explicit user feedback regarding their subjective preferences related to the robot attributes and engagement features.
|
|
Experimental: Implicit CBT SAR Personalization for 6 weeks
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBI daily exercises with an implicitly personalized CBT SAR in the participants' homes.
The personalized re-engagement feedback provided by the SAR will be based on machine learning methods applied to implicit visual and auditory cues.
|
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBI daily exercises with an implicitly personalized CBT SAR in the participants' homes.
The personalized re-engagement feedback provided by the SAR will be based on machine learning methods applied to implicit visual and auditory cues.
|
|
Placebo Comparator: Control CBT SAR for 6 weeks
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBT daily exercises with a non-personalized CBT SAR in the participants' homes.
Participants will not have the capability to personalize the robot's attributes, and this condition will be a control baseline comparison group for the personalized intervention conditions described above.
|
College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBT daily exercises with a non-personalized CBT SAR.
Participants will not have the capability to personalize the robot's attributes, and this condition will be a control baseline comparison group for the personalized intervention conditions described above.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of user-spoken words during interactions with SAR
Time Frame: During each session, through study completion, approximately 6 weeks.
|
Using transcriptions of the interactions, the investigators will count the number of words uttered by the participant.
|
During each session, through study completion, approximately 6 weeks.
|
|
Overall length of interaction sessions
Time Frame: Through the duration of the study, approximately 6 weeks.
|
Using the interaction data from the robot interface, the investigators will collect the time that the participant started the interaction with the robot and the time that the interaction ended.
|
Through the duration of the study, approximately 6 weeks.
|
|
Number of days participants complete CBT exercises (adherence)
Time Frame: Through study completion, approximately 6 weeks.
|
Using the interaction data from the robot interface, the investigators will collect the number of days that the participant interacts with the system at least once during the day
|
Through study completion, approximately 6 weeks.
|
|
Outcomes Questionnaire-45.2
Time Frame: Once in weeks 1, 3, 6 of the study.
|
The total reported symptom distress value from the symptom distress subscale.
Question scale (0-4).
A higher total score indicates higher distress overall, and higher scores for question subsets indicate worse outcomes for symptom distress, interpersonal relations, and social role.
|
Once in weeks 1, 3, 6 of the study.
|
|
Modified Working Alliance Inventory-Short Revised
Time Frame: Once in weeks 2, 4, 6 of study.
|
Repeated daily measure for assessing the quality of the relationship with the SAR companion.
Question scale (1-5).
Higher scores indicate stronger alliance.
|
Once in weeks 2, 4, 6 of study.
|
|
Sustem Usability Scale
Time Frame: Once on Week 2 Day 4 and Week 6 Day 4.
|
The total reported usability score for evaluating participant perception of SAR companion's usability.
Question responses scale from strongly agree to strongly disagree.
Responses should not indicate trends in participant outcomes, but should instead help the investigators understand participants' perception of the system.
|
Once on Week 2 Day 4 and Week 6 Day 4.
|
|
Semi-structured interview
Time Frame: One interview for 30 minutes - 120 minutes at the end of the 6 week study.
|
Focus group interviews with the investigators and participants will be used to process for collecting qualitative feedback and insights.
The investigators will use this data to perform thematic analysis of participant responses while using the system.
|
One interview for 30 minutes - 120 minutes at the end of the 6 week study.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
GAD-7 Questionnaire
Time Frame: Once in weeks 2, 4, 6 of the study.
|
Screening measure for identifying students with elevated levels of anxiety.
Question scale (0-3).
A higher total score indicates higher levels of anxiety.
|
Once in weeks 2, 4, 6 of the study.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH139134-At-Home
- R01MH139134 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder (GAD)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Wayne State UniversityNational Institute of Mental Health (NIMH)RecruitingAnxiety Disorders | Generalized Anxiety Disorder (GAD)United States
-
AbbVieRecruitingGeneralized Anxiety Disorder (GAD)United States, Puerto Rico
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
PsyScaleNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
National Health Research Institutes, TaiwanNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
National Taiwan University HospitalNot yet recruitingGeneralized Anxiety Disorder (GAD)
-
Ibn Haldun UniversityCompletedWell Being | Anxiety Disorder (Panic Disorder or GAD)Turkey (Türkiye)
-
Queen's UniversityDiamond Therapeutics Inc.; Kingston Health Sciences CentreRecruitingGeneralized Anxiety Disorder (GAD)Canada
-
Edgemont Pharmaceuticals, LLCCompletedGeneralized Anxiety Disorder (GAD)United States
Clinical Trials on Control CBT SAR for 6 weeks
-
Jordan Miller, Graduate StudentPhysiotherapy Foundation of CanadaCompletedResponses of People With Neck Pain Being Treated With Varying Doses of Manual Therapy: A Pilot StudyWhiplash InjuriesCanada
-
Rambam Health Care CampusCompleted
-
Praxis Precision MedicinesRecruitingFocal SeizureUnited States, Spain
-
Sigmund Freud PrivatUniversitatMedical University of GrazRecruitingAlcohol Use Disorder (AUD) | Nicotine Addiction | Healthy Adult Participants | Substance Use Disorder (SUD)Austria
-
SRH Gesundheitszentrum Bad HerrenalbRecruiting
-
Riphah International UniversityCompletedMuscle Weakness | Neck Pain | Range of Motion | BreastfeedingPakistan
-
Ersta Sköndal University CollegeKarolinska Institutet; Region StockholmCompletedInsomnia | Bereavement
-
Kirby InstituteCompletedHepatitis CAustralia, United States, United Kingdom, New Zealand, Switzerland, Canada, Germany, Netherlands
-
Massachusetts General HospitalCompletedDistal Radius Fracture | Finger StiffnessUnited States